Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Meda has announced that the FDA has approved its registration application for azelastine eye drops in unit dose.
Subscribe to our email newsletter
The substance azelastine is an antihistamine and the eye drop formulation is approved for treatment of allergic conjunctivitis in adults and pediatrics.
Meda is conducting a broad development program for the azelastine substance, both as azelastine eye drops and azelastine nasal spray. Azelastine eye drops sample is one part of that development program.